FDG-PET/CT SUVmax Predicts Recurrence Risk of Resected Pleuropulmonary Solitary Fibrous Tumors
Tumor metabolic activity on FDG-PET/CT is predictive of SFT recurrence. Preoperative SUVmax correlates with known histopathologic high-risk features and validated risk scores. Preoperative FDG-PET/CT should be performed before SFT resection to assist in prognostication.
Authors
- Jennifer M. Boland (ORCID: https://orcid.org/0000-0002-2723-9586)
- Brendan W. Lunn
- Janani Reisenauer (ORCID: https://orcid.org/0000-0002-8824-6691)
- Matthew Aizpuru (ORCID: https://orcid.org/0000-0002-6030-6226)
- K.Robert Shen
- Luis F. Tapias (ORCID: https://orcid.org/0000-0003-0064-460X)
- Sahar A. Saddoughi
- Stephen D. Cassivi (ORCID: https://orcid.org/0000-0001-9600-0897)
- Dennis A. Wigle (ORCID: https://orcid.org/0000-0003-2407-1340)
Institutions
- Mayo Clinic (US)
Publication Details
- Journal
- JTO Clinical and Research Reports
- Published
- 2025-12-13
- DOI
- https://doi.org/10.1016/j.jtocrr.2025.100942
- Primary Topic
- Soft tissue tumor case studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00